STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues [Abstract]
Total revenue	$ (1,781)	$ 2,917	$ 7,222	$ 3,136
Operating expenses:
Selling, general and administrative	16,083	20,054	48,943	30,310
Research and development	2,405	6,510	10,673	14,975
Cost of product revenue	351	145	1,257	145
Cost of collaboration revenue	84	125	858	329
Total operating expenses	18,923	26,834	61,731	45,759
Loss from operations	(20,704)	(23,917)	(54,509)	(42,623)
Other (expense) income:
Interest income	221	822	1,212	1,948
Interest expense	(2,376)	(1,657)	(7,063)	(1,657)
Other expense	(1)	(50)	(17)	(49)
Total other (expense) income, net	(2,156)	(885)	(5,868)	242
Net loss	$ (22,860)	$ (24,802)	$ (60,377)	$ (42,381)
Net loss per share, basic	$ (0.49)	$ (0.54)	$ (1.3)	$ (0.94)
Net loss per share, diluted	$ (0.49)	$ (0.54)	$ (1.3)	$ (0.94)
Weighted-average common shares outstanding, basic	46,805,427	46,073,932	46,597,883	45,015,900
Weighted-average common shares outstanding, diluted	46,805,427	46,073,932	46,597,883	45,015,900
Product [Member]
Revenues [Abstract]
Total revenue	$ (1,865)	$ 2,792	$ 6,259	$ 2,792
Collaboration [Member]
Revenues [Abstract]
Total revenue	$ 84	$ 125	$ 963	$ 344

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.